[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 216 Introduced in Senate (IS)]

103d CONGRESS
  2d Session
S. RES. 216

To express the sense of the Senate regarding breast and cervical cancer 
                               screening.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                 May 25 (legislative day, May 16), 1994

 Mr. Murkowski (for himself, Mr. Stevens, Mr. Lugar, and Mr. Cochran) 
submitted the following resolution; which was referred to the Committee 
                      on Labor and Human Resources

_______________________________________________________________________

                               RESOLUTION


 
To express the sense of the Senate regarding breast and cervical cancer 
                               screening.

Whereas mammography is the most reliable method of detecting the early onset of 
        breast cancer in women;
Whereas Pap smears are the most reliable method of detecting the onset of 
        cervical and uterine cancers in women;
Whereas 180,000 women are diagnosed with breast cancer each year and 46,000 die 
        from the disease;
Whereas 45,500 women are diagnosed with cervical and uterine cancers each year 
        and 10,000 die from these diseases;
Whereas the American College of Obstetrics and Gynecology recommend that women 
        have annual pelvic exams and Pap smears beginning at the age of 18 or 
        when a women becomes sexually active; and
Whereas the American College of Obstetrics and Gynecology, the American Cancer 
        Society, the American Medical Association, and the American Medical 
        Womens' Association recommend that women between the ages of 40 and 50 
        have mammograms every 1 to 2 years: Now, therefore, be it
    Resolved, That it is the sense of the Senate that any comprehensive 
health care reform measures passed by the Senate contain provisions 
that maintain that early detection and preventative screening for 
breast and cervical cancers not be artificially limited by Federal 
mandates, but be provided in a manner consistent with sound scientific 
research, allowing for physician discretion.

                                      <all>